These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23828652)

  • 1. Real-time FDG PET/CT-guided bone biopsy in a patient with two primary malignancies.
    Win AZ; Aparici CM
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1787-8. PubMed ID: 23828652
    [No Abstract]   [Full Text] [Related]  

  • 2. FDG PET/CT for bone and soft-tissue biopsy.
    Nanni C; Gasbarrini A; Cappelli A; Sandler I; Graziani T; Guidalotti P; Golfieri R; Boriani S; Fanti S
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1333-4. PubMed ID: 25693761
    [No Abstract]   [Full Text] [Related]  

  • 3. (18)F-FDG PET/CT and (99m)Tc-MDP imaging of non-small cell lung carcinoma osseous metastases.
    Komissarova M; Wong KK; Fig LM
    J Nucl Med Technol; 2012 Mar; 40(1):66-7, 70. PubMed ID: 22279236
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG PET/CT differentiating two malignant tumors in the same patient.
    Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
    Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
    [No Abstract]   [Full Text] [Related]  

  • 5. Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.
    Mojtahedi A; Solomon SB; Ulaner GA
    Clin Nucl Med; 2013 Mar; 38(3):217-8. PubMed ID: 23357824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
    Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
    J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroendocrine pulmonary neoplasms: improved diagnosis by DOTATOC- vs. FDG-PET/CT].
    Frechen D; Temur Y; Cornelissen C; Kweider S; Krüger S
    Pneumologie; 2011 Oct; 65(10):628-30. PubMed ID: 22015488
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.
    Cerci JJ; Tabacchi E; Bogoni M
    PET Clin; 2016 Jan; 11(1):57-64. PubMed ID: 26590444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.
    Lee JE; Jang JY; Jeong SW; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Jin SY; Choi DL
    World J Gastroenterol; 2012 Jun; 18(23):2979-87. PubMed ID: 22736922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT.
    Chong A; Song HC; Oh JR; Ha JM; Min JJ; Bom HS; Choi YD; Lee JS
    Clin Nucl Med; 2012 Aug; 37(8):798-800. PubMed ID: 22785516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT superscan in prostate cancer.
    Bailly M; Besse H; Kerdraon R; Metrard G; Gauvain S
    Clin Nucl Med; 2014 Oct; 39(10):912-4. PubMed ID: 24566401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblastic healing response: discordant PET/CT findings.
    Gemmel F; Eshuis SA; van Vollenhoven F; Gemmel P
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):184-5. PubMed ID: 21997719
    [No Abstract]   [Full Text] [Related]  

  • 14. The appearance of osseous PEComa on F-18 FDG PET/CT.
    Rakheja R; Abikhzer G; Alabed YZ; Nahal A; Lisbona R
    Clin Nucl Med; 2012 Feb; 37(2):190-2. PubMed ID: 22228350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
    Jadvar H; Henderson RW; Conti PS
    Mol Imaging Biol; 2006; 8(3):193-200. PubMed ID: 16565910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
    Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
    Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negative.
    Maffione AM; Lisato LC; Rasi A; Marzola MC; Colletti PM; Rubello D
    Clin Nucl Med; 2015 Feb; 40(2):e134-6. PubMed ID: 24999681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.
    Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Kulkarni M; Laskar SG; Rangarajan V
    Nucl Med Commun; 2014 Aug; 35(8):864-9. PubMed ID: 24751701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A; Mittra E; Dick DW; Gambhir SS
    Mol Imaging Biol; 2012 Apr; 14(2):252-9. PubMed ID: 21479710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG-PET/CT Guided Biopsy in Angiosarcoma of Bone: Diagnosis, Staging and Beyond.
    Matti A; Farolfi A; Frisoni T; Fanti S; Nanni C
    Clin Nucl Med; 2018 Feb; 43(2):e48-e49. PubMed ID: 29215413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.